DK0765877T3 - 5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse - Google Patents

5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Info

Publication number
DK0765877T3
DK0765877T3 DK96402044T DK96402044T DK0765877T3 DK 0765877 T3 DK0765877 T3 DK 0765877T3 DK 96402044 T DK96402044 T DK 96402044T DK 96402044 T DK96402044 T DK 96402044T DK 0765877 T3 DK0765877 T3 DK 0765877T3
Authority
DK
Denmark
Prior art keywords
furan
indano
tetrahydronaphtho
processes
preparation
Prior art date
Application number
DK96402044T
Other languages
Danish (da)
English (en)
Inventor
Aimee Dessinges
Valerie Audinot
Jean-Louis Peglion
Joel Vian
Mark Millan
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK0765877T3 publication Critical patent/DK0765877T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/92Naphthofurans; Hydrogenated naphthofurans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK96402044T 1995-09-29 1996-09-26 5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse DK0765877T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9511446A FR2739379B1 (fr) 1995-09-29 1995-09-29 Nouveaux composes amines de 5,6,7,8-tetrahydronaphto(2,3-b) furane et d'indano(5,6-b)furane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
DK0765877T3 true DK0765877T3 (da) 2004-04-19

Family

ID=9483043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96402044T DK0765877T3 (da) 1995-09-29 1996-09-26 5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse

Country Status (15)

Country Link
US (1) US5665765A (zh)
EP (1) EP0765877B1 (zh)
JP (1) JPH09110855A (zh)
CN (1) CN1075067C (zh)
AT (1) ATE256675T1 (zh)
AU (1) AU707883B2 (zh)
CA (1) CA2186337C (zh)
DE (1) DE69631104T2 (zh)
DK (1) DK0765877T3 (zh)
ES (1) ES2213171T3 (zh)
FR (1) FR2739379B1 (zh)
NO (1) NO314501B1 (zh)
NZ (1) NZ299465A (zh)
PT (1) PT765877E (zh)
ZA (1) ZA968167B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7216866B2 (en) * 2003-04-28 2007-05-15 Kyocera Mita Corporation Sheet transport path switching mechanism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470990A (en) * 1983-03-14 1984-09-11 Ayerst, Mckenna & Harrison Inc. 6,7,8,9-Tetrahydronaphtho(1,2-B)furan-8-amine derivatives and their use as dopamine receptor stimulants
FR2613364B1 (fr) * 1987-04-01 1989-06-09 Adir Nouvelles amines tricycliques derivees du tetrahydro-5, 6, 7, 8 naphto (2, 3b) dihydro-2, 3 furanne, et du tetrahydro-6, 7, 8, 9 5h-benzocyclohepta (2, 3b) dihydro-2, 3 furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2613365B1 (fr) * 1987-04-01 1989-07-28 Adir Nouveaux derives de l'amino tetrahydro-5, 6, 7, 8 naphto (2, 3b) furanne, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
FR2725985B1 (fr) * 1994-10-21 1996-11-15 Adir Nouveaux composes tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA2186337A1 (fr) 1997-03-30
NO964072D0 (no) 1996-09-27
DE69631104D1 (de) 2004-01-29
NO964072L (no) 1997-04-01
ATE256675T1 (de) 2004-01-15
ES2213171T3 (es) 2004-08-16
PT765877E (pt) 2004-04-30
JPH09110855A (ja) 1997-04-28
EP0765877A1 (fr) 1997-04-02
ZA968167B (en) 1997-05-02
EP0765877B1 (fr) 2003-12-17
CA2186337C (fr) 2002-01-01
NZ299465A (en) 1997-06-24
NO314501B1 (no) 2003-03-31
AU707883B2 (en) 1999-07-22
CN1075067C (zh) 2001-11-21
US5665765A (en) 1997-09-09
DE69631104T2 (de) 2004-09-02
FR2739379B1 (fr) 1997-10-24
FR2739379A1 (fr) 1997-04-04
AU6589796A (en) 1997-04-10
CN1150151A (zh) 1997-05-21

Similar Documents

Publication Publication Date Title
MX9203150A (es) Nuevos esteres de acidos tienilcarboxilicos de aminoalcoholes, sus productos de cuaternizacion y las composiciones farmaceuticas que los contienen.
DK0562956T3 (da) Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2138956T3 (es) Imidazoquinoxalinonas, sus analogos aza y procedimiento para su preparacion.
DK0521787T3 (da) Vanadiumkomplekser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
BR9803295A (pt) preparos e composições farmacêuticas contendo os mesmos.
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2142030T3 (es) Nuevos compuestos espiro-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0559079T3 (da) Substituerede aminophosphonatderivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende derivaterne
DE69016567T2 (de) Prostaglandinanaloge enthaltende Lipidemulsion.
MX9300875A (es) Procedimiento para la preparacion de compuestos azabiciclicos.
NO894349D0 (no) Tienopyridin-type mevalonolaktoner.
DK0765877T3 (da) 5,6,7,8-tetrahydronaphtho-[2,3-b]-furan- og indano-[5,6-b]-furan-aminoforbindelser, fremgangsmåder til fremstilling heraf og farmaceutiske sammensætninger indeholdende disse
ITMI911853A1 (it) Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
FR2713644B1 (fr) Nouveaux analogues de l'éburnane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES537558A0 (es) Un procedimiento para la preparacion del isomero r (dextrogiro)
ES2061712T3 (es) Nuevos derivados sustituidos de 20,21-dinoreburnamenina, su procedimiento de preparacion y los nuevos productos intermedios asi obtenidos, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
DK0632035T3 (da) Hidtil ukendte aminoalkylchromoner, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
DK0574312T3 (da) Diacylglycerolnicotinater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
ATE80396T1 (de) Alpha-hydroxy-azolylethyloxirane und diese enthaltende fungizide.
MY104781A (en) 3-(n-methyl-n-alkyl)-amino 2-methoxymethylene propan 1- ol derivatives, a preparation process of the same and therapeutical compositions containing them.
ATE61341T1 (de) N-substituierte, estergruppen enthaltende acrylamide.
FR2368495A1 (fr) Procede de preparation d'acides 2-carbamoylphosphiniques n-substitues
ES2132429T3 (es) Disacaridos de antraciclina, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
MX9300136A (es) Alfa-aril-alfa-hidroxi-beta-imidazolinil-propionamidas, procedimiento para su obtencion y medicamentos que las contienen.